The freezing of biopharmaceutical products involves many challenges. One of them is to find a compromise between fast process times, low investment costs, low running costs, and storage under stable conditions. Our answer at Boehringer Ingelheim BioXcellence™ is BI-STAR™.
BI-STAR™ is a new integrated concept for controlled freezing, storage, transportation and thawing of formulated bulk drug substance of high value.
The integrated concept of BI-STAR™ includes disposable bags, a stainless-steel full rigid shell to protect the bag, a standard plate freezer, and a storage system. Compared with other commercially available solutions, the BI-STAR™ system requires much lower investment and operating costs and eliminates many of the risks associated with disposable bags.
The advantages of BI-STAR™ at a glance: